Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK PathwayFu-Shun Hsu, Kuo‐How Huang, Kuan-Lin Kuo et al.|International Journal of Molecular Sciences|2019Cited by 25
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinomaWei‐Chou Lin, Kuo‐How Huang, Fu-Shun Hsu et al.|Journal of Molecular Medicine|2018Cited by 9